2025 ESMO Poster: Comprehensive Epigenomic Profiling of Plasma ctDNA Enables Assessment of Drug Target Expression in SCLC
2025 ESMO Poster: Comprehensive Epigenomic Profiling of Plasma ctDNA Enables Assessment of Drug Target Expression in SCLC
2025 ASCO Poster: Robust characterization of response & resistance to 177Lu-PSMA-617 in mCRPC by plasma-based epigenomic profiling
2025 ASCO Poster: Robust characterization of response & resistance to 177Lu-PSMA-617 in mCRPC by plasma-based epigenomic profiling
2025 ASCO Poster: Cell-free circulating chromatin profiles enable epigenomic characterization of mechanisms of response and resistance to sacituzumab govitecan in breast cancer
2025 ASCO Poster: Cell-free circulating chromatin profiles enable epigenomic characterization of mechanisms of response and resistance to sacituzumab govitecan in breast cancer
Precede Biosciences Presents ASCO 2025 Data Highlighting the Ability of its Liquid Biopsy Platform to Reveal the Biology Underlying Response and Resistance to ADCs and Radiopharmaceuticals
Precede Biosciences Presents ASCO 2025 Data Highlighting the Ability of its Liquid Biopsy Platform to Reveal the Biology Underlying Response and Resistance to ADCs and Radiopharmaceuticals
2025 AACR Poster: Systematic and Robust Prediction of Gene Expression Using Comprehensive Epigenomic Profiling of Plasma cfDNA
2025 AACR Poster: Systematic and Robust Prediction of Gene Expression Using Comprehensive Epigenomic Profiling of Plasma cfDNA
Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for Thousands of Tumor-Specific Genes from a Simple Blood Test
Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for Thousands of Tumor-Specific Genes from a Simple Blood Test
2025 ASCO GU Poster: Epigenomic profiling of circulating chromatin for early detection and monitoring of neuroendocrine prostate cancer
2025 ASCO GU Poster: Epigenomic profiling of circulating chromatin for early detection and monitoring of neuroendocrine prostate cancer
2024 SABCS Poster: Epigenomic characterization of ER transcriptional activation via liquid biopsy
2024 SABCS Poster: Epigenomic characterization of ER transcriptional activation via liquid biopsy
Precede Biosciences Presents a Novel ER Transcriptional Dependency Index at SABCS 2024 Designed to Further Inform Use of Endocrine Therapy from a Simple Blood Test
Precede Biosciences Presents a Novel ER Transcriptional Dependency Index at SABCS 2024 Designed to Further Inform Use of Endocrine Therapy from a Simple Blood Test
2024 AACR LBx Presentation: Comprehensive epigenomic profiling from plasma to inform drug development, cancer biology, and therapy selection
2024 AACR LBx Presentation: Comprehensive epigenomic profiling from plasma to inform drug development, cancer biology, and therapy selection